Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Incyte - 31 Year Stock Price History | INCY

Historical daily share price chart and data for Incyte since 1993 adjusted for splits and dividends. The latest closing stock price for Incyte as of April 26, 2024 is 51.68.
  • The all-time high Incyte stock closing price was 152.66 on March 15, 2017.
  • The Incyte 52-week high stock price is 75.74, which is 46.6% above the current share price.
  • The Incyte 52-week low stock price is 50.27, which is 2.7% below the current share price.
  • The average Incyte stock price for the last 52 weeks is 60.03.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Incyte Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 58.4736 65.4500 66.5900 51.1800 51.6800 -17.69%
2023 66.1166 79.5500 86.0100 52.1600 62.7900 -21.83%
2022 74.7658 73.9700 84.1100 66.0200 80.3200 9.43%
2021 77.9284 86.4500 100.5000 63.3400 73.4000 -15.61%
2020 88.8053 85.9700 109.6900 63.1800 86.9800 -0.39%
2019 81.9818 63.5600 95.7200 63.5600 87.3200 37.32%
2018 72.8748 100.8900 100.9800 58.5000 63.5900 -32.86%
2017 121.3776 102.3200 152.6600 93.5600 94.7100 -5.55%
2016 83.5442 103.3200 108.1000 63.0500 100.2700 -7.54%
2015 102.6879 73.7600 131.4700 71.4900 108.4500 48.34%
2014 57.1143 51.2300 78.8900 43.1000 73.1100 44.40%
2013 28.9761 17.0000 51.3400 17.0000 50.6300 204.82%
2012 19.2983 14.9900 25.8400 14.7800 16.6100 10.66%
2011 15.7089 16.5200 20.7600 11.7800 15.0100 -9.36%
2010 13.4671 9.5000 17.1700 9.4100 16.5600 81.78%
2009 4.7656 3.8500 9.4000 2.0500 9.1100 140.37%
2008 8.3997 9.9800 12.4200 2.4900 3.7900 -62.29%
2007 7.1488 6.0200 10.7800 4.8100 10.0500 72.09%
2006 4.8336 5.3400 6.2000 3.5800 5.8400 9.36%
2005 7.1163 9.6400 9.6600 4.2700 5.3400 -46.55%
2004 8.3024 6.8200 10.9600 5.4500 9.9900 46.05%
2003 4.6660 4.9090 6.9100 2.6700 6.8400 50.00%
2002 8.0137 19.4000 19.6900 2.9800 4.5600 -76.54%
2001 18.1810 22.5600 30.6300 10.7600 19.4400 -21.86%
2000 47.9850 44.8150 140.2500 23.5600 24.8800 -17.07%
1999 12.9288 18.5000 31.5650 8.2800 30.0000 60.51%
1998 17.8036 21.3750 25.1900 9.2500 18.6900 -16.93%
1997 16.6527 12.7500 22.5000 10.6250 22.5000 74.76%
1996 9.2842 7.0300 12.8750 6.1250 12.8750 106.00%
1995 4.4132 3.4075 6.2500 3.2825 6.2500 80.12%
1994 2.4212 2.1875 3.9075 1.7188 3.4700 54.22%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.491B $3.696B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.489B 14.44
Vertex Pharmaceuticals (VRTX) United States $102.789B 29.59
Regeneron Pharmaceuticals (REGN) United States $97.763B 23.70
Bristol Myers Squibb (BMY) United States $90.596B 6.08
CSL (CSLLY) Australia $87.140B 0.00
GSK (GSK) United Kingdom $84.784B 10.63
Gilead Sciences (GILD) United States $81.266B 16.20
Moderna (MRNA) United States $40.654B 0.00
Biogen (BIIB) United States $29.478B 13.50
Argenex SE (ARGX) Netherlands $21.906B 0.00
BioNTech SE (BNTX) Germany $20.613B 21.05
Illumina (ILMN) United States $19.278B 139.14
Genmab (GMAB) Denmark $18.157B 23.27
Alnylam Pharmaceuticals (ALNY) United States $18.100B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.508B 60.87
BeiGene (BGNE) Cayman Islands $14.208B 0.00
Sarepta Therapeutics (SRPT) United States $12.039B 0.00
Exact Sciences (EXAS) United States $10.672B 0.00
Bio-Techne Corp (TECH) United States $9.850B 36.64
QIAGEN (QGEN) Netherlands $9.375B 19.41
Repligen (RGEN) United States $9.250B 95.76
Roivant Sciences (ROIV) United Kingdom $8.768B 0.00
Legend Biotech (LEGN) United States $8.080B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Ascendis Pharma (ASND) Denmark $7.973B 0.00
Viking Therapeutics (VKTX) United States $7.590B 0.00
Intra-Cellular Therapies (ITCI) United States $6.983B 0.00
Exelixis (EXEL) United States $6.937B 36.77
Cytokinetics (CYTK) United States $6.777B 0.00
Vaxcyte (PCVX) United States $6.532B 0.00
Apellis Pharmaceuticals (APLS) United States $5.779B 0.00
Blueprint Medicines (BPMC) United States $5.553B 0.00
Halozyme Therapeutics (HALO) United States $4.887B 15.08
CRISPR Therapeutics AG (CRSP) Switzerland $4.561B 0.00
Krystal Biotech (KRYS) United States $4.439B 0.00
Zealand Pharma (ZLDPF) Denmark $4.439B 0.00
Nuvalent (NUVL) United States $4.233B 0.00
Alkermes (ALKS) Ireland $4.135B 21.82
Immunovant (IMVT) United States $4.032B 0.00
Insmed (INSM) United States $3.702B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.609B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Biohaven (BHVN) United States $3.401B 0.00
Axsome Therapeutics (AXSM) United States $3.388B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.309B 0.00
SpringWorks Therapeutics (SWTX) United States $3.261B 0.00
Fortrea Holdings (FTRE) United States $3.249B 0.00
Iovance Biotherapeutics (IOVA) United States $3.223B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.025B 0.00
Amicus Therapeutics (FOLD) United States $3.012B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.890B 0.00
IDEAYA Biosciences (IDYA) United States $2.887B 0.00
Arcellx (ACLX) United States $2.738B 0.00
MorphoSys AG (MOR) Germany $2.731B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.687B 0.00
Merus (MRUS) Netherlands $2.637B 0.00
Certara (CERT) United States $2.611B 56.21
Janux Therapeutics (JANX) United States $2.433B 0.00
CG Oncology (CGON) United States $2.412B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.294B 0.00
Vericel (VCEL) United States $2.199B 0.00
Arvinas (ARVN) United States $2.159B 0.00
Denali Therapeutics (DNLI) United States $2.132B 0.00
Vera Therapeutics (VERA) United States $2.107B 0.00
Guardant Health (GH) United States $2.089B 0.00
Kymera Therapeutics (KYMR) United States $2.046B 0.00
Celldex Therapeutics (CLDX) United States $2.027B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.000B 0.00
Apogee Therapeutics (APGE) United States $1.968B 0.00
Keros Therapeutics (KROS) United States $1.955B 0.00
Geron (GERN) United States $1.947B 0.00
Intellia Therapeutics (NTLA) United States $1.931B 0.00
Avidity Biosciences (RNA) United States $1.900B 0.00
Galapagos (GLPG) Belgium $1.887B 0.00
Sana Biotechnology (SANA) United States $1.874B 0.00
Structure Therapeutics (GPCR) United States $1.816B 0.00
Twist Bioscience (TWST) United States $1.797B 0.00
Beam Therapeutics (BEAM) United States $1.778B 0.00
NeoGenomics (NEO) United States $1.768B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.748B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.674B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.643B 13.65
Myriad Genetics (MYGN) United States $1.627B 0.00
Bavarian Nordic (BVNRY) Denmark $1.621B 5.32
Inhibrx (INBX) United States $1.616B 0.00
Zai Lab (ZLAB) China $1.562B 0.00
Edgewise Therapeutics (EWTX) United States $1.484B 0.00
ADMA Biologics Inc (ADMA) United States $1.470B 0.00
Dynavax Technologies (DVAX) United States $1.462B 0.00
Kura Oncology (KURA) United States $1.447B 0.00
Neumora Therapeutics (NMRA) United States $1.440B 0.00
Protagonist Therapeutics (PTGX) United States $1.437B 0.00
Morphic Holding (MORF) United States $1.400B 0.00
Gyre Therapeutics (GYRE) United States $1.395B 0.00
ANI Pharmaceuticals (ANIP) United States $1.369B 16.83
Arcus Biosciences (RCUS) United States $1.340B 0.00
Akero Therapeutics (AKRO) United States $1.309B 0.00
Ligand Pharmaceuticals (LGND) United States $1.246B 15.43
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.244B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.237B 0.00
Spyre Therapeutics (SYRE) United States $1.174B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.154B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.154B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.146B 0.00
MannKind (MNKD) United States $1.131B 0.00
Belite Bio (BLTE) United States $1.108B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.102B 0.00
Scholar Rock Holding (SRRK) United States $1.087B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.085B 0.00
AbCellera Biologics (ABCL) Canada $1.063B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Abivax SA (ABVX) France $0.991B 0.00
Liquidia Technologies (LQDA) United States $0.940B 0.00
MiMedx (MDXG) United States $0.922B 208.17
Immunome (IMNM) United States $0.851B 0.00
ALX Oncology Holdings (ALXO) United States $0.844B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.832B 0.00
Cullinan Therapeutics (CGEM) United States $0.829B 0.00
Immatics (IMTX) Germany $0.828B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.805B 0.00
Viridian Therapeutics (VRDN) United States $0.797B 0.00
Tyra Biosciences (TYRA) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.788B 0.00
89BIO (ETNB) United States $0.786B 0.00
Tango Therapeutics (TNGX) United States $0.782B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.780B 0.00
PureTech Health (PRTC) United States $0.742B 0.00
Cytek Biosciences (CTKB) United States $0.737B 0.00
CARGO Therapeutics (CRGX) United States $0.720B 0.00
Pliant Therapeutics (PLRX) United States $0.717B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.704B 0.00
Mesoblast (MESO) Australia $0.702B 0.00
Pharming Group (PHAR) Netherlands $0.701B 0.00
Praxis Precision Medicines (PRAX) United States $0.700B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.693B 0.00
Kyverna Therapeutics (KYTX) United States $0.687B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.677B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.650B 0.00
EnGene Holdings (ENGN) United States $0.642B 0.00
Disc Medicine (IRON) United States $0.640B 0.00
Dianthus Therapeutics (DNTH) United States $0.616B 0.00
Stoke Therapeutics (STOK) United States $0.609B 0.00
Nurix Therapeutics (NRIX) United States $0.608B 0.00
Aerovate Therapeutics (AVTE) United States $0.601B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
HilleVax (HLVX) United States $0.598B 0.00
Pharming Group (PHGUF) Netherlands $0.591B 0.00
WAVE Life Sciences (WVE) Singapore $0.580B 0.00
Cogent Biosciences (COGT) United States $0.575B 0.00
Northwest Biotherapeutics (NWBO) United States $0.574B 0.00
Zymeworks (ZYME) United States $0.572B 0.00
Nuvation Bio (NUVB) United States $0.571B 0.00
Cabaletta Bio (CABA) United States $0.570B 0.00
Novavax (NVAX) United States $0.553B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
Mineralys Therapeutics (MLYS) United States $0.548B 0.00
GH Research (GHRS) Ireland $0.546B 0.00
Castle Biosciences (CSTL) United States $0.536B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
ArriVent BioPharma (AVBP) United States $0.520B 0.00
CureVac (CVAC) Germany $0.517B 0.00
Oric Pharmaceuticals (ORIC) United States $0.517B 0.00
Prime Medicine (PRME) United States $0.516B 0.00
AnaptysBio (ANAB) United States $0.516B 0.00
Absci (ABSI) United States $0.504B 0.00
Astria Therapeutics (ATXS) United States $0.504B 0.00
Adlai Nortye (ANL) Cayman Islands $0.497B 0.00
Arbutus Biopharma (ABUS) United States $0.488B 0.00
Allogene Therapeutics (ALLO) United States $0.487B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Applied Therapeutics (APLT) United States $0.483B 0.00
Celcuity (CELC) United States $0.480B 0.00
Shattuck Labs (STTK) United States $0.465B 0.00
Avid Bioservices (CDMO) United States $0.465B 0.00
Humacyte (HUMA) United States $0.464B 0.00
Alector (ALEC) United States $0.461B 0.00
IGM Biosciences (IGMS) United States $0.450B 0.00
Fulcrum Therapeutics (FULC) United States $0.443B 0.00
Fate Therapeutics (FATE) United States $0.440B 0.00
Editas Medicine (EDIT) United States $0.429B 0.00
C4 Therapeutics (CCCC) United States $0.428B 0.00
Third Harmonic Bio (THRD) United States $0.426B 0.00
ACELYRIN, INC (SLRN) United States $0.419B 0.00
Entrada Therapeutics (TRDA) United States $0.415B 0.00
Annexon (ANNX) United States $0.413B 0.00
Travere Therapeutics (TVTX) United States $0.410B 0.00
Voyager Therapeutics (VYGR) United States $0.403B 2.40
MaxCyte (MXCT) United States $0.385B 0.00
Neurogene (NGNE) United States $0.384B 0.00
FibroBiologics (FBLG) United States $0.381B 0.00
ITeos Therapeutics (ITOS) United States $0.380B 0.00
Alto Neuroscience (ANRO) United States $0.380B 0.00
Anika Therapeutics (ANIK) United States $0.380B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.379B 0.00
PepGen (PEPG) United States $0.379B 0.00
Replimune (REPL) United States $0.378B 0.00
Biomea Fusion (BMEA) United States $0.376B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.368B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.351B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
TScan Therapeutics (TCRX) United States $0.349B 0.00
Precigen (PGEN) United States $0.348B 0.00
Mersana Therapeutics (MRSN) United States $0.346B 0.00
Revance Therapeutics (RVNC) United States $0.343B 0.00
Caribou Biosciences (CRBU) United States $0.340B 0.00
Nkarta (NKTX) United States $0.337B 0.00
Tenaya Therapeutics (TNYA) United States $0.331B 0.00
Rani Therapeutics Holdings (RANI) United States $0.329B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Solid Biosciences (SLDB) United States $0.323B 0.00
Jasper Therapeutics (JSPR) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Ocugen (OCGN) United States $0.304B 0.00
MeiraGTx Holdings (MGTX) United States $0.302B 0.00
Terns Pharmaceuticals (TERN) United States $0.300B 0.00
Kamada (KMDA) Israel $0.299B 22.61
Nautilus Biotechnology (NAUT) United States $0.295B 0.00
XOMA (XOMA) United States $0.295B 0.00
Contineum Therapeutics (CTNM) United States $0.292B 0.00
Ventyx Biosciences (VTYX) United States $0.286B 0.00
Erasca (ERAS) United States $0.285B 0.00
CorMedix Inc (CRMD) United States $0.284B 0.00
Anavex Life Sciences (AVXL) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.273B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.271B 0.00
Rapt Therapeutics (RAPT) United States $0.271B 0.00
Werewolf Therapeutics (HOWL) United States $0.269B 0.00
Inozyme Pharma (INZY) United States $0.267B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.262B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.258B 89.60
ChromaDex (CDXC) United States $0.255B 0.00
XBiotech (XBIT) United States $0.250B 0.00
Invivyd (IVVD) United States $0.247B 0.00
Renovaro (RENB) United States $0.244B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Puma Biotechnology (PBYI) United States $0.235B 10.61
Verastem (VSTM) United States $0.233B 0.00
Prima BioMed (IMMP) Australia $0.229B 0.00
AC Immune (ACIU) Switzerland $0.226B 0.00
23andMe Holding (ME) United States $0.222B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Coherus BioSciences (CHRS) United States $0.219B 0.00
UniQure (QURE) Netherlands $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Opthea (OPT) Australia $0.212B 0.00
Ovid Therapeutics (OVID) United States $0.212B 0.00
Compass Therapeutics (CMPX) United States $0.204B 0.00
G1 Therapeutics (GTHX) United States $0.202B 0.00
Lifecore Biomedical (LFCR) United States $0.201B 0.00
Poseida Therapeutics (PSTX) United States $0.198B 0.00
INmune Bio (INMB) United States $0.197B 0.00
Adverum Biotechnologies (ADVM) United States $0.195B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.190B 0.00
Candel Therapeutics (CADL) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.189B 0.00
Codexis (CDXS) United States $0.186B 0.00
Cardiff Oncology (CRDF) United States $0.178B 0.00
Elevation Oncology (ELEV) United States $0.177B 0.00
Trevi Therapeutics (TRVI) United States $0.175B 0.00
Agenus (AGEN) United States $0.174B 0.00
Alimera Sciences (ALIM) United States $0.173B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Adocia (ADOCY) France $0.169B 0.00
Kodiak Sciences (KOD) United States $0.167B 0.00
Inventiva S.A (IVA) France $0.166B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.159B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.159B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
ScPharmaceuticals (SCPH) United States $0.157B 0.00
Zura Bio (ZURA) United States $0.156B 0.00
CervoMed (CRVO) United States $0.154B 0.00
BioStem Technologies (BSEM) $0.153B 0.00
Gossamer Bio (GOSS) United States $0.152B 0.00
Annovis Bio (ANVS) United States $0.150B 0.00
Adicet Bio (ACET) United States $0.149B 0.00
I-Mab (IMAB) China $0.146B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Cellectis S.A (CLLS) France $0.138B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.130B 0.00
VistaGen Therapeutics (VTGN) United States $0.127B 0.00
Sagimet Biosciences (SGMT) United States $0.125B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Vor Biopharma (VOR) $0.116B 0.00
Nuvectis Pharma (NVCT) United States $0.116B 0.00
Immunic (IMUX) United States $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Cartesian Therapeutics (RNAC) United States $0.113B 0.00
Seres Therapeutics (MCRB) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.108B 0.00
ATyr Pharma (LIFE) United States $0.108B 0.00
TELA Bio (TELA) United States $0.108B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Sangamo Therapeutics (SGMO) United States $0.104B 0.00
Rezolute (RZLT) United States $0.104B 0.00
Adagene (ADAG) China $0.104B 0.00
Emergent Biosolutions (EBS) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.102B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Vigil Neuroscience (VIGL) United States $0.097B 0.00
BioXcel Therapeutics (BTAI) United States $0.097B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
Elicio Therapeutics (ELTX) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.092B 0.00
Allakos (ALLK) United States $0.089B 0.00
Genelux (GNLX) United States $0.089B 0.00
BeyondSpring (BYSI) United States $0.088B 0.00
Abeona Therapeutics (ABEO) United States $0.087B 0.00
Curis (CRIS) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Aileron Therapeutics (ALRN) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.084B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.081B 0.00
Leap Therapeutics (LPTX) United States $0.081B 0.00
Eton Pharmaceuticals (ETON) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.86
Cognition Therapeutics (CGTX) United States $0.075B 0.00
Passage Bio (PASG) United States $0.075B 0.00
Gritstone Bio (GRTS) United States $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
Affimed (AFMD) Germany $0.074B 0.00
YS Biopharma (YS) China $0.074B 0.00
Athira Pharma (ATHA) United States $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.073B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
Elutia (ELUT) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.070B 0.00
Alpha Teknova (TKNO) United States $0.069B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Instil Bio (TIL) United States $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Equillium (EQ) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Rallybio (RLYB) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.061B 0.00
Celularity (CELU) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Lantern Pharma (LTRN) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
CalciMedica (CALC) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
HCW Biologics (HCWB) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.054B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
Genenta Science S.p.A (GNTA) Italy $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.050B 0.00
Prenetics Global (PRE) Cayman Islands $0.045B 0.00
NKGen Biotech (NKGN) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
Bolt Biotherapeutics (BOLT) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.043B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Beyond Air (XAIR) United States $0.042B 0.00
Apollomics (APLM) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Aadi Bioscience (AADI) United States $0.041B 0.00
Carmell (CTCX) United States $0.040B 0.00
Cara Therapeutics (CARA) United States $0.038B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
IN8bio (INAB) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
KALA BIO (KALA) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
ABVC BioPharma (ABVC) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Vaxxinity (VAXX) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00